The story of Sildenafil presents a challenging picture for investors. While the initial launch generated substantial gains, the expiration of its intellectual property protection opened the floodgates to off-brand https://jesseipce561404.blogminds.com/viagra-and-big-pharma-a-precarious-bet-38681565